BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 18802410)

  • 1. Impact of expanded newborn screening--United States, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Sep; 57(37):1012-5. PubMed ID: 18802410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naming and counting disorders (conditions) included in newborn screening panels.
    Sweetman L; Millington DS; Therrell BL; Hannon WH; Popovich B; Watson MS; Mann MY; Lloyd-Puryear MA; van Dyck PC
    Pediatrics; 2006 May; 117(5 Pt 2):S308-14. PubMed ID: 16735257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening: an overview.
    Carreiro-Lewandowski E
    Clin Lab Sci; 2002; 15(4):229-38. PubMed ID: 12776783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDC Grand Rounds: Newborn screening and improved outcomes.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(21):390-3. PubMed ID: 22647744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening in Australia and New Zealand.
    Webster D; ;
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():69-70. PubMed ID: 15906698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of newborn screening.
    Levy PA
    J Dev Behav Pediatr; 2010 Sep; 31(7):622-31. PubMed ID: 20814260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects.
    Garg U; Dasouki M
    Clin Biochem; 2006 Apr; 39(4):315-32. PubMed ID: 16563365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From developing guidelines to implementing legislation: actions of the US Advisory Committee on Heritable Disorders in Newborns and Children toward advancing and improving newborn screening.
    Howell RR; Lloyd-Puryear MA
    Semin Perinatol; 2010 Apr; 34(2):121-4. PubMed ID: 20207261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem mass spectrometry program implementation challenges for state newborn screening programs: national survey of barriers and issues.
    Feuchtbaum L; Faulkner L; Verghese S
    Pediatrics; 2006 May; 117(5 Pt 2):S253-60. PubMed ID: 16735251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of new genetic diseases into statewide newborn screening: New England experience.
    Comeau AM; Larson C; Eaton RB
    Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):35-41. PubMed ID: 14755432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening newborns: just the beginning. Newborn screening and tracking diagnosed children into adulthood varies among states.
    Johnson A
    State Legis; 2008 Apr; 34(4):20-3. PubMed ID: 18411494
    [No Abstract]   [Full Text] [Related]  

  • 13. Practices and perceptions of long-term follow-up among state newborn screening programs.
    Hoff T; Hoyt A
    Pediatrics; 2006 Jun; 117(6):1922-9. PubMed ID: 16740832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening in Delaware.
    Bartoshesky LE
    Del Med J; 2003 May; 75(5):181-9. PubMed ID: 12815929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding metabolic screening of newborns: can the health care industry do better than public health?
    Mulvihill JJ; Blackett PR; Palmer SE
    J Okla State Med Assoc; 2003 Oct; 96(10):477-81. PubMed ID: 14619602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes from tandem mass spectrometry (MS/MS) workshops in the United States and the performance evaluation of MS/MS laboratories.
    Hannon H; Lim T; Adam B; Therrell B
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():121-6. PubMed ID: 15906714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening in North Carolina: the evolution of policy and practice.
    Kirkman HN
    N C Med J; 2008; 69(2):92-7. PubMed ID: 18605155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
    Bishop Hubbard H
    Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Model project for updating neonatal screening in Bavaria: concept and initial results].
    Liebl B; Fingerhut R; Röschinger W; Muntau A; Knerr I; Olgemöller B; Zapf A; Roscher AA
    Gesundheitswesen; 2000 Apr; 62(4):189-95. PubMed ID: 10844815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening: toward a uniform screening panel and system--executive summary.
    American College of Medical Genetics Newborn Screening Expert Group
    Pediatrics; 2006 May; 117(5 Pt 2):S296-307. PubMed ID: 16735256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.